ACE Report Cover
Silver-Impregnated Fibrous Hydrocolloid Dressings for the Treatment of Fracture Blisters
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
TRAUMA
Silver-Impregnated Fibrous Hydrocolloid Dressings for the Treatment of Fracture Blisters .
Verified
This report has been verified by one or more authors of the original publication.

Randomized Controlled Trial Comparing Silver-Impregnated Fibrous Hydrocolloid Dressings With Silver Sulfadiazine Cream Dressings for the Treatment of Fracture Blisters to Determine Time to Surgical Readiness.

J Orthop Trauma. 2021 Aug 1;35(8): 442-447.

One hundred and twenty eight patients with fracture blisters and associated fractures requiring operative fixation were randomized to receive silver-impregnated fibrous hydrocolloid dressing (SFH) (n=64) or silver sulfadiazine (SS) (n=64) prior to surgery. The main outcome of interest was surgical readiness determined by complete re-epithelialization of the affected sites. Secondary outcomes of interest were cost-effectiveness, time to surgery and length of stay. The SFH group had a significantly shorter time to surgical readiness than the SS group. The SFH group cost less than the SS group with respect to total cost of treatment until surgical readiness. No differences in time to surgery or length of stay were noted.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Silver-Impregnated Fibrous Hydrocolloid Dressings for the Treatment of Fracture Blisters. ACE Report. 2021;95(1):1. Available from: https://myorthoevidence.com/AceReport/Show/silver-impregnated-fibrous-hydrocolloid-dressings-for-the-treatment-of-fracture-blisters

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report